東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The role of p53-independent apoptoti...

Tan, Tingting.

Linked to FindBook

Google Book

Amazon

博客來

The role of p53-independent apoptotic pathways in tumorigenesis.

Record Type:	Electronic resources : Monograph/item
Title/Author:	The role of p53-independent apoptotic pathways in tumorigenesis./
Author:	Tan, Tingting.
Description:	173 p.
Notes:	Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0109.
Contained By:	Dissertation Abstracts International67-01B.
Subject:	Biology, Molecular. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3203357
ISBN:	9780542519451

The role of p53-independent apoptotic pathways in tumorigenesis.
Tan, Tingting.

The role of p53-independent apoptotic pathways in tumorigenesis. - 173 p.

Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0109.

Thesis (Ph.D.)--Rutgers The State University of New Jersey - New Brunswick and University of Medicine and Dentistry of New Jersey, 2006.

Apoptosis is a critical process for the maintenance of cellular homeostasis and prevention of cancer. BCL-2 family proteins play a central role in the regulation of apoptosis and modulate death signaling through mitochondrial pathway.{09}The strong impact of the BCL-2 family on tumor development is well illustrated by findings with baby mouse kidney epithelial (BMK) cells immortalized by E1A and dominant negative p53 (p53DD). Immortalized BMK (iBMK) cells from mice deficient for both BAX and BAK, or that overexpress BCL-2, readily form tumors in nude mice, whereas those retaining functional BAX and/or BAK do not, suggesting that a p53-independent, but BAX and BAK-dependent apoptotic pathway is implicated in tumor suppression. Hence, understanding the molecular events regulating this p53-independent apoptotic pathway may provide insights into tumorigenesis and reveal novel targets for effective therapeutic approaches to cancer treatment. We show that in epithelial cells, ischemic conditions in the tumor microenvironment cause induction of the BH3-only protein PUMA, and BAX-and BAK-mediated apoptosis that suppresses tumorigenesis independent of the RB and p53 pathways. Blockade of this p53-independent apoptotic pathway by either loss-of-function of BAX and BAK or gain-of-function of BCL-2 in vivo does not merely extend viability, but also allows survival of genetically unstable cells which may further promote tumor development. Furthermore, determining the mechanism of apoptosis induction by the chemotherapeutic drug paclitaxel revealed that BH3-only protein BIM suppressed tumorigenesis and was required for paclitaxel responsiveness.{09}The targeting of BIM for degradation in proteasomes by the H-ras/MAPK pathway was the molecular basis for paclitaxel resistance in tumors with activating mutations in RAS, and paclitaxel responsiveness was restored by joint administration of the proteasome inhibitor Velcade. Thus rational combinatorial chemotherapy using proteasome inhibitors to enhance chemosensitivity to paclitaxel in tumors where the H-ras/MAPK pathway is activated may be therapeutically beneficial, implying that relating tumor genotype to effective treatment regimens is essential for successful therapeutic outcome. Finally, studying the enhanced tumorigenesis of tumor derived cell lines (TDCLs) after in vivo selection showed that multiple capabilities may be selected for and cooperate with each other during tumorigenesis, revealing the complexity of cancer development.

ISBN: 9780542519451Subjects--Topical Terms:

1017719
Biology, Molecular.

The role of p53-independent apoptotic pathways in tumorigenesis.
LDR:03496nmm 2200289 4500 001 1824148
005 20061128082948.5
008 130610s2006 eng d
020 $a 9780542519451
035 $a (UnM)AAI3203357
035 $a AAI3203357
040 $a UnM $c UnM
100 1 $a Tan, Tingting. $3 1913238
245 1 4 $a The role of p53-independent apoptotic pathways in tumorigenesis.
300 $a 173 p.
500 $a Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0109.
500 $a Adviser: Eileen White.
502 $a Thesis (Ph.D.)--Rutgers The State University of New Jersey - New Brunswick and University of Medicine and Dentistry of New Jersey, 2006.
520 $a Apoptosis is a critical process for the maintenance of cellular homeostasis and prevention of cancer. BCL-2 family proteins play a central role in the regulation of apoptosis and modulate death signaling through mitochondrial pathway.{09}The strong impact of the BCL-2 family on tumor development is well illustrated by findings with baby mouse kidney epithelial (BMK) cells immortalized by E1A and dominant negative p53 (p53DD). Immortalized BMK (iBMK) cells from mice deficient for both BAX and BAK, or that overexpress BCL-2, readily form tumors in nude mice, whereas those retaining functional BAX and/or BAK do not, suggesting that a p53-independent, but BAX and BAK-dependent apoptotic pathway is implicated in tumor suppression. Hence, understanding the molecular events regulating this p53-independent apoptotic pathway may provide insights into tumorigenesis and reveal novel targets for effective therapeutic approaches to cancer treatment. We show that in epithelial cells, ischemic conditions in the tumor microenvironment cause induction of the BH3-only protein PUMA, and BAX-and BAK-mediated apoptosis that suppresses tumorigenesis independent of the RB and p53 pathways. Blockade of this p53-independent apoptotic pathway by either loss-of-function of BAX and BAK or gain-of-function of BCL-2 in vivo does not merely extend viability, but also allows survival of genetically unstable cells which may further promote tumor development. Furthermore, determining the mechanism of apoptosis induction by the chemotherapeutic drug paclitaxel revealed that BH3-only protein BIM suppressed tumorigenesis and was required for paclitaxel responsiveness.{09}The targeting of BIM for degradation in proteasomes by the H-ras/MAPK pathway was the molecular basis for paclitaxel resistance in tumors with activating mutations in RAS, and paclitaxel responsiveness was restored by joint administration of the proteasome inhibitor Velcade. Thus rational combinatorial chemotherapy using proteasome inhibitors to enhance chemosensitivity to paclitaxel in tumors where the H-ras/MAPK pathway is activated may be therapeutically beneficial, implying that relating tumor genotype to effective treatment regimens is essential for successful therapeutic outcome. Finally, studying the enhanced tumorigenesis of tumor derived cell lines (TDCLs) after in vivo selection showed that multiple capabilities may be selected for and cooperate with each other during tumorigenesis, revealing the complexity of cancer development.
590 $a School code: 0801.
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Biology, Cell. $3 1017686
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0307
690 $a 0379
690 $a 0992
710 2 0 $a Rutgers The State University of New Jersey - New Brunswick and University of Medicine and Dentistry of New Jersey. $3 1023857
773 0 $t Dissertation Abstracts International $g 67-01B.
790 1 0 $a White, Eileen, $e advisor
790 $a 0801
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3203357